Cargando…
Targeting Oncogenic Rewiring of Lipid Metabolism for Glioblastoma Treatment
Glioblastoma (GBM) is the most malignant primary brain tumor. Despite increasing research on GBM treatment, the overall survival rate has not significantly improved over the last two decades. Although recent studies have focused on aberrant metabolism in GBM, there have been few advances in clinical...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698497/ https://www.ncbi.nlm.nih.gov/pubmed/36430293 http://dx.doi.org/10.3390/ijms232213818 |